In summary, our study has revealed that low PIP-TMZ treatment inhibits the proliferation of glioma cells by reducing cell viability, inducing apoptosis and activation of caspase-8/-9/-3, activation of JNK/p38 MAPKs, inhibiting wound healing, and MMP depolarization. The gene discussed is CASP8; the disease is glioma.